Skip to main content
Premium Trial:

Request an Annual Quote

Bit of a Dip

The success rate for competing research project grant applications submitted to the US National Institutes of Health fell in 2013, writes Sally Rockey, the deputy director for extramural research at NIH, at the Rock Talk blog.

She says that nearly 49,600 competing research project grant applications were submitted to NIH in 2013, down from just over 51,300 applications in fiscal year 2012. This year, NIH made 8,310 competing research project grant awards as compared to 9,032 in 2012. That, Rockey says, works out to a 16.8 percent overall success rate for applications submitted this year, while 2012 saw a 17.2 percent success rate.

Some might have expected a greater drop in that success rate, Rockey says, as NIH awarded some 8 percent fewer competing awards in 2013 than in 2012.

That drop in the number of awards is mostly due to the across-the-board sequester cuts that trimmed some 5 percent off of the agency's budget, and estimates from earlier in the year feared that grant success rates would fall to 15 percent.

This smaller decrease in success rates may partially be explained by the lower number of applications made, Rockey notes.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.